Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases

Affiliations

• ¹ Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.
• ² Institute of Pharmacy, Freie Universität of Berlin, Berlin, Germany.
• ³ Institute of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany.
• ⁴ Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany.
• ⁵ Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. [email protected].
• ⁶ Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. [email protected].
• ⁷ Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany. [email protected].
• ⁸ Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany. [email protected].
• ⁹ Max-Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany. [email protected].